Intercomparaciones relacionadas con trasplantes, tipaje HLA, KIR, quimerismo y antígenos de neutrófilos y plaquetas, anticuerpos anti HLA, anti HPA y GSTT1 
- Gestor Subprograma: M. Carmen Martín Alonso
Serología de clase I
- Gestor Subprograma: M. Carmen Martín Alonso
HLA B-27
HLA-B*57:01HLAs de susceptibilidad a Enfermedad Celiaca- Gestor Subprograma: M. Carmen Martín Alonso
PRUEBAS CRUZADAS: Citometría y citotoxicidad (PBMCs, LT, LB)
- Gestor Subprograma: M. Carmen Martín Alonso
anti HLA: CDC, screening and single antigen
- Gestor Subprograma: M. Carmen Martín Alonso
Low resolution typing of loci HLA-A, HLA-B (and HLA-C as an option), HLA-DRB1(optional: HLA-DRB3, HLA-DRB4, HLA-DRB5,HLA-DQA1, HLA-DQB1)
- Gestor Subprograma: M. Carmen Martín Alonso
High resolution typing of loci HLA-A, HLA-B (and HLA-C as an option), HLA-DRB1(optional: HLA-DRB3, HLA-DRB4, HLA-DRB5,HLA-DQA1, HLA-DQB1, HLA-DPA1, HLA-DPB1).
High resolution typing is defined as the identification of HLA alleles that encode the same protein sequence within the antigen binding site
D1.4.1
HLA alleles must be identified at the level of resolution which defines the first and second fields according to WHO nomenclature by at least resolving all ambiguities:
D1.4.1.1
Resulting from polymorphisms located within exons 2 and 3 for HLA class I loci, and exon 2 for HLA class II loci
D1.4.1.2
That encompass a null allele, wherever the polymorphism is located, unless it can be demonstrated that an expressed antigen is present on the cells
- Gestor Subprograma: M. Carmen Martín Alonso
Chimerism assays on blood mixtures
- Gestor Subprograma: M. Carmen Martín Alonso
2DL1, 2DL2, 2DL3 , 2DL4 , 2DL5 , 2DS1 , 2DS2 , 2DS3 , 2DS4 , 2DS5 , 2DP1 , 3DL1 , 3DL2 , 3DL3 , 3DS1 , 3DP1
- Gestor Subprograma: M. Carmen Martín Alonso
Plaquetary antigen typing HPA (1,2,5,15)
- Gestor Subprograma: M. Carmen Martín Alonso
Plaquetary antigen typing HPA (1,2,5,15)
- Gestor Subprograma: M. Carmen Martín Alonso
Detección de Aloanticuerpos dirigidos contra la GSTT1 y alelos del gen GSTT1
